These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1919574)

  • 1. Proteolysis of microtubule-associated protein 2 and tubulin by cathepsin D.
    Johnson GV; Litersky JM; Whitaker JN
    J Neurochem; 1991 Nov; 57(5):1577-83. PubMed ID: 1919574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.
    Bednarski E; Lynch G
    J Neurochem; 1996 Nov; 67(5):1846-55. PubMed ID: 8863489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-stimulated degradation of oxidatively modified superoxide dismutase by cathepsin D in cardiac tissue extracts.
    Strack PR; Waxman L; Fagan JM
    Biochem Biophys Res Commun; 1996 Feb; 219(2):348-53. PubMed ID: 8604990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pH dependence of breakdown of various purified brain proteins by cathepsin D preparations.
    Banay-Schwartz M; Bracco F; Dahl D; Deguzman T; Turk V; Lajtha A
    Neurochem Int; 1985; 7(4):607-14. PubMed ID: 20492966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The lysosomal pathway of prolactin degradation in the mammary gland: kinetics of prolactin hydrolysis by cathepsin D and the peptides formed thereby].
    Marinchenko GV; Khropycheva RP
    Biokhimiia; 1989 Apr; 54(4):629-39. PubMed ID: 2758071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.
    Kenessey A; Nacharaju P; Ko LW; Yen SH
    J Neurochem; 1997 Nov; 69(5):2026-38. PubMed ID: 9349548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of Alzheimer's beta-amyloid protein by human cathepsin D.
    McDermott JR; Gibson AM
    Neuroreport; 1996 Sep; 7(13):2163-6. PubMed ID: 8930981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of microtubule associated protein 2 and sensitivity of pancreatic tumours to docetaxel.
    Veitia R; David S; Barbier P; Vantard M; Gounon P; Bissery MC; Fellous A
    Br J Cancer; 2000 Aug; 83(4):544-9. PubMed ID: 10945505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins.
    Matus A; Green GD
    Biochemistry; 1987 Dec; 26(25):8083-6. PubMed ID: 3327517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic lipids enhance cathepsin D cleavage of the myelin basic protein.
    Williams KR; Williams ND; Konigsberg W; Yu RK
    J Neurosci Res; 1986; 15(2):137-45. PubMed ID: 2421004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity of cerebral cathepsin D and high-Mr aspartic endopeptidase.
    Azaryan AV; Galoyan AA
    J Neurosci Res; 1988 Feb; 19(2):268-71. PubMed ID: 3285013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The susceptibility of MAP-2 to proteolytic degradation increases when bound to tubulin.
    Grau E; Felipo V; Miñana MD; Grisolía S
    Neurochem Res; 1992 Oct; 17(10):967-71. PubMed ID: 1508306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activation of internalized cholera toxin within hepatic endosomes by cathepsin D.
    Merlen C; Fayol-Messaoudi D; Fabrega S; El Hage T; Servin A; Authier F
    FEBS J; 2005 Sep; 272(17):4385-97. PubMed ID: 16128808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D.
    Conner GE; Richo G
    Biochemistry; 1992 Feb; 31(4):1142-7. PubMed ID: 1734961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pH on the degradation of bovine myelin basic protein by bovine brain cathepsin.
    Whitaker JN; Seyer JM
    Biochim Biophys Acta; 1981 Oct; 661(2):334-41. PubMed ID: 6170337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The breakdown of the individual neurofilament proteins by cathepsin D.
    Banay-Schwartz M; Dahl D; Hui KS; Lajtha A
    Neurochem Res; 1987 Apr; 12(4):361-7. PubMed ID: 3600962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ATP, vanadate, and molybdate on cathepsin D-catalyzed proteolysis.
    Pillai S; Zull JE
    J Biol Chem; 1985 Jul; 260(14):8384-9. PubMed ID: 3891755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study.
    Johnson GV; Litersky JM; Jope RS
    J Neurochem; 1991 May; 56(5):1630-8. PubMed ID: 2013758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine brain cathepsin D: inhibition by pepstatin and binding to concanavalin A.
    Young PR; Karunatilake C
    Int J Biochem; 1992 Feb; 24(2):229-33. PubMed ID: 1733788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.